Donna Edwards - Exactech Vice President - Legal

President

Ms. Donna Edwards is Vice President, Legal and General Counsel of Exactech Inc. She was employed by Exactech since January 2001, serving in the capacity of Interim Compliance Officer from April 2011 to August 2011, Corporationrationrate Attorney from February 2003 to April 2011, and Legal Coordinator from January 2001 to February 2003. Previously, she was employed by Exactech as Regulatory Affairs Coordinator from June 1996 to 1998 since 2011.
Age 43
Tenure 13 years
Phone352 378-2617
Webwww.exac.com
Edwards received her B.S. degree from Duke University and her J.D. degree from the University of Alabama.

Exactech Management Efficiency

The company has return on total asset (ROA) of 0.0669 % which means that it generated a profit of $0.0669 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0826 %, meaning that it created $0.0826 on every $100 dollars invested by stockholders. Exactech's management efficiency ratios could be used to measure how well Exactech manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 14 M in liabilities with Debt to Equity (D/E) ratio of 5.5, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Exactech has a current ratio of 4.0, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Exactech until it has trouble settling it off, either with new capital or with free cash flow. So, Exactech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Exactech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Exactech to invest in growth at high rates of return. When we think about Exactech's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Tobin TornehlSensient Technologies
50
Godefroy MotteEastman Chemical
56
Mark ChongCDW Corp
47
Steve MorrisSensient Technologies
60
Olivier GuiotHawkins
39
Clark JordanEastman Chemical
59
Brian ColemanHudson Technologies
62
John CollopySensient Technologies
45
Oliver GuiotHawkins
38
Nat KrishnamurtiHudson Technologies
52
Stephen RolfsSensient Technologies
59
Sherri ManningQ2 Holdings
48
Mark CoxEastman Chemical
54
Jonathan PriceQ2 Holdings
40
Frederick KulevichCDW Corp
58
Theresa MoranHawkins
54
Scott KingEastman Chemical
51
Christina RotherCDW Corp
54
Rekha GarapatiQ2 Holdings
42
William McLainEastman Chemical
51
Matthew TrokaCDW Corp
47
Exactech, Inc. develops, manufactures, markets, distributes, and sells orthopedic implant devices, related surgical instrumentation, and biologic services. Exactech, Inc. was founded in 1985 and is headquartered in Gainesville, Florida. Exactech operates under Medical Appliances Equipment classification in USA and traded on NASDAQ. It employs 733 people. Exactech (EXAC) is traded on NASDAQ Exchange in USA and employs 733 people.

Management Performance

Exactech Leadership Team

Elected by the shareholders, the Exactech's board of directors comprises two types of representatives: Exactech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Exactech. The board's role is to monitor Exactech's management team and ensure that shareholders' interests are well served. Exactech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Exactech's outside directors are responsible for providing unbiased perspectives on the board's policies.
Christine Nusse, Director
Richard Smith, Independent Director
R Petty, Executive Chairman of the Board
Francois Nusse, Chairman of the Board, CEO
Jerome Nusse, Director
Guillaume Nusse, Director
Andrew Krusen, Director
Charles Nusse, Director
Bruce Thompson, Sr. VP and General Manager of Biologics and Spine Division
James Binch, Independent Director
Monique Prissard, Director - Permanent Representative of Ets Charles Nusse
Fern Watts, Independent Director
David Petty, CEO and President and Director
Betty Petty, Vice President - Administration, Corporate Secretary
Donna Edwards, Vice President - Legal
William Locander, Independent Director
Dominique Daridan, Director
JeanClaude Nusse, Senior Vice President Director
Joel Phillips, CFO, Treasurer
Celine Nusse, Director
Frederic Nusse, Director
Gary Miller, Co-Founder and Executive VP of RandD
Caroline Valentin, Director
JeanOlivier Roussat, Executive Vice President
JeanMarie Nusse, Senior Vice President Director
William Petty, Executive Chairman of the Board

Exactech Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Exactech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Exactech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Exactech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exactech will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Exactech information on this page should be used as a complementary analysis to other Exactech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Consideration for investing in Exactech Stock

If you are still planning to invest in Exactech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exactech's history and understand the potential risks before investing.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bonds Directory
Find actively traded corporate debentures issued by US companies
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Global Correlations
Find global opportunities by holding instruments from different markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios